Dealmaking

Carlyle portfolio well-insulated from tariffs threat – Schwartz

The alternatives giant anticipates limited impact from Trump's trade levies given its investments are predominantly US-focused, according to CEO Harvey Schwartz.

Private equity’s growing interest in RIAs; The Riverside Company details Wall Street Prep investment

Private equity bets on registered investment advisors.

The Riverside Company invests in online financial training provider Wall Street Prep

'M&A presents an attractive growth driver and we plan to pursue companies with complementary solutions,' says Peter Tsang, co-chief investment officer, Riverside Capital Appreciation.

M&A activity in the RIA industry surging to new heights

PE activity in the wealth management sector dates to over a decade ago, but the pace of investment activity and industry consolidation has significantly accelerated over the last four or five years.

Archimed plans next diagnostics play; MidEuropa’s Diagnostyka IPO performs; US tariff winners and losers

Tower Peak Partners, Inflexion and Adams Street Partners open new offices.

Archimed to buy another European diagnostics company following Diesse exit

Archimed sold Diesse for €125 million in January, after spending six years expanding the company through internationalization and innovation.

US dealmaking off to slowest start in 10+ years; One Equity raises $2.4bn for OEP IX; Kimmeridge’s McMahon eyes growing demand for energy

Dealmaking slowed down in January, according to data.

Kimmeridge's Neil McMahon: 'Demand for energy is only increasing'

McMahon will be a featured speaker at PEI Group’s upcoming NEXUS 2025 summit in Orlando, Florida, March 10-12.

Arctos-backed Hayfin MBO represents 'trillion-dollar' opportunity

There are countless private markets firms that need a partner to help them grow in an era of scarce alpha and capital, says Arctos managing partner Ian Charles.

GPs skeptical of European IPO revival; Private capital ‘crucial’ in UK nuclear energy development

Lincoln International managing director Carlos Candil shares his views following the UK government announcement to put Britain back “in the global race” for nuclear energy.